Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-02-14 | Mr. Mark MosslerCAO | 6,15k | 0,00 | Derivative Exercise and Retained Stock | - | 5,79k | -1 704,16% |
| 2026-02-14 | Mr. Mark MosslerCAO | -3,27k | 6,18k | Derivative Exercise and Sale | 1,89 | 5,79k | - |
| 2026-02-14 | Dr. Leonard M. J. ReynoChief Medical Officer | 14,37k | 0,00 | Derivative Exercise and Retained Stock | - | 25,48k | 129,39% |
| 2026-02-14 | Dr. Leonard M. J. ReynoChief Medical Officer | -16,58k | 31,33k | Derivative Exercise and Sale | 1,89 | 25,48k | - |
| 2026-02-13 | Mr. Scott N. BoyleChief Business Officer | 16,95k | 0,00 | Derivative Exercise and Retained Stock | - | 37,78k | 81,35% |
| 2026-02-13 | Mr. Scott N. BoyleChief Business Officer | -9,00k | 17,02k | Derivative Exercise and Sale | 1,89 | 37,78k | - |
| 2026-02-13 | Ms. Kelly A. SchickCPO | 16,95k | 0,00 | Derivative Exercise and Retained Stock | - | 38,86k | 77,34% |
| 2026-02-13 | Ms. Kelly A. SchickCPO | -9,00k | 17,02k | Derivative Exercise and Sale | 1,89 | 38,86k | - |
| 2026-02-14 | Ms. Paige MahaneyChief Scientific Officer | 4,60k | 0,00 | Derivative Exercise and Retained Stock | - | 18,16k | 33,96% |
| 2026-02-14 | Ms. Paige MahaneyChief Scientific Officer | -2,45k | 4,62k | Derivative Exercise and Sale | 1,89 | 18,16k | - |
| 2026-02-14 | Mr. Andrew J. HirschCEO, President & Director | 53,91k | 0,00 | Derivative Exercise and Retained Stock | - | 135,21k | 66,32% |
| 2026-02-14 | Mr. Andrew J. HirschCEO, President & Director | -48,21k | 91,12k | Derivative Exercise and Sale | 1,89 | 135,21k | - |
| 2026-02-13 | Ms. Kendra R. AdamsCFO and Head of Corporate Affairs & Treasurer | 17,46k | 0,00 | Derivative Exercise and Retained Stock | - | 45,17k | 62,98% |
| 2026-02-13 | Ms. Kendra R. AdamsCFO and Head of Corporate Affairs & Treasurer | -17,24k | 32,59k | Derivative Exercise and Sale | 1,89 | 45,17k | - |
| 2026-01-16 | Dr. Leonard M. J. ReynoChief Medical Officer | -10,00k | 22,20k | Vente | 2,22 | 11,11k | -47,38% |
| 2025-10-28 | Ms. Paige MahaneyChief Scientific Officer | 13,56k | 0,00 | Derivative Exercise and Retained Stock | - | 13,56k | - |
| 2025-10-28 | Ms. Paige MahaneyChief Scientific Officer | -5,64k | 14,56k | Derivative Exercise and Sale | 2,58 | 13,56k | - |
| 2025-09-18 | Ms. Kendra R. AdamsCFO and Head of Corporate Affairs & Treasurer | 3,48k | 0,00 | Derivative Exercise and Retained Stock | - | 27,72k | 14,33% |
| 2025-09-18 | Ms. Kendra R. AdamsCFO and Head of Corporate Affairs & Treasurer | -2,78k | 9,21k | Derivative Exercise and Sale | 3,32 | 27,72k | - |
| 2025-07-10 | Dr. Leonard M. J. ReynoChief Medical Officer | 7,94k | 0,00 | Derivative Exercise and Retained Stock | - | 21,11k | 60,34% |
| 2025-07-10 | Dr. Leonard M. J. ReynoChief Medical Officer | -7,38k | 14,69k | Derivative Exercise and Sale | 1,99 | 21,11k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
